Samsara BioCapital as of Dec. 31, 2020
Portfolio Holdings for Samsara BioCapital
Samsara BioCapital holds 43 positions in its portfolio as reported in the December 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Jiya Acquisition Corp | 51.0 | $507M | 5.2k | 97078.50 | |
| Nkarta (NKTX) | 12.6 | $125M | 2.0M | 61.47 | |
| Chinook Therapeutics | 5.1 | $50M | 3.2M | 15.86 | |
| Forma Therapeutics Hldgs | 5.0 | $50M | 1.4M | 34.90 | |
| Sutro Biopharma (STRO) | 3.7 | $36M | 1.7M | 21.71 | |
| Syros Pharmaceuticals | 2.2 | $22M | 2.2M | 9.97 | |
| Allakos | 2.1 | $21M | 146k | 140.00 | |
| Springworks Therapeutics (SWTX) | 1.9 | $19M | 263k | 72.52 | |
| Iveric Bio | 1.6 | $16M | 2.4M | 6.91 | |
| Odonate Therapeutics Ord | 1.6 | $16M | 815k | 19.20 | |
| Intercept Pharmaceuticals In | 1.0 | $10M | 404k | 24.70 | |
| Aclaris Therapeutics (ACRS) | 0.9 | $8.8M | 1.4M | 6.47 | |
| Verona Pharma Spons Ads (VRNA) | 0.8 | $7.8M | 1.1M | 7.00 | |
| Curevac N V (CVAC) | 0.8 | $7.7M | 95k | 81.07 | |
| Atreca Inc Cl A (BCEL) | 0.8 | $7.7M | 475k | 16.15 | |
| Aeglea Biotherapeutics | 0.7 | $7.0M | 884k | 7.87 | |
| Cogent Biosciences (COGT) | 0.7 | $6.6M | 589k | 11.23 | |
| Rhythm Pharmaceuticals (RYTM) | 0.6 | $6.0M | 201k | 29.73 | |
| Equillium (EQ) | 0.6 | $5.7M | 1.1M | 5.35 | |
| Bctg Acquisition Corp | 0.6 | $5.7M | 500k | 11.44 | |
| Panacea Acquisition Corp. Unit | 0.5 | $5.1M | 400k | 12.76 | |
| Alpine Immune Sciences | 0.5 | $5.0M | 399k | 12.60 | |
| Kronos Bio | 0.5 | $5.0M | 166k | 29.87 | |
| Kala Pharmaceuticals | 0.4 | $4.1M | 601k | 6.78 | |
| Albireo Pharma | 0.4 | $3.8M | 100k | 37.51 | |
| Rocket Pharmaceuticals (RCKT) | 0.4 | $3.5M | 64k | 54.84 | |
| Fulcrum Therapeutics (FULC) | 0.3 | $3.4M | 294k | 11.71 | |
| Novavax (NVAX) | 0.3 | $3.4M | 30k | 111.51 | |
| Bcls Acquisition Corp | 0.3 | $3.3M | 300k | 11.14 | |
| Vistagen Therapeutics | 0.3 | $3.2M | 1.6M | 1.94 | |
| Allovir (ALVR) | 0.3 | $3.2M | 82k | 38.44 | |
| Consonance Hfw Acquisition C | 0.3 | $3.1M | 300k | 10.47 | |
| Avadel Pharmaceuticals Spons Adr | 0.3 | $2.9M | 434k | 6.68 | |
| Lifesci Acquisition Ii Corp | 0.2 | $2.1M | 200k | 10.67 | |
| Geron Corporation (GERN) | 0.2 | $1.9M | 1.2M | 1.59 | |
| Hookipa Pharma Inc equity | 0.1 | $1.4M | 130k | 11.09 | |
| Kalvista Pharmaceuticals (KALV) | 0.1 | $1.3M | 67k | 18.98 | |
| Silverback Therapeutics (SPRY) | 0.1 | $1.2M | 25k | 46.36 | |
| BioNTech SE Spons Ads (BNTX) | 0.1 | $880k | 11k | 81.52 | |
| Kadmon Hldgs | 0.1 | $685k | 165k | 4.15 | |
| Catabasis Pharmaceuticals Ord | 0.1 | $642k | 300k | 2.14 | |
| Ngm Biopharmaceuticals | 0.1 | $552k | 18k | 30.29 | |
| Amarin Corp Spons Adr New | 0.0 | $122k | 25k | 4.88 |
